Systematic Reviews of Treatments for Liver Diseases

Follow the links below to find summaries of systematic reviews of the evidence for treatments for liver diseases.

Reviewed December 2011

Printer friendly page Printer friendly page

Related HealthInsite Topics

Systematic Reviews of Drug Treatments for Liver Diseases

HealthInsite Topic Page
Links to systematic reviews of the evidence for the effectiveness of drug treatments for liver diseases.

14 Resources Found

Results 1 to 14 displayed.

Title:   Probiotics for patients with hepatic encephalopathy
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Hepatic encephalopathy is a disorder of the brain function as a result of liver failure and/or portosystemic shunt. It results in confusion, drowsiness, coma, and in some patients, in death. While the cause of hepatic encephalopathy is not fully unders...
Date:   Sep 2011
Title:   Ursodeoxycholic acid for cystic fibrosis-related liver disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Problems of bile composition and flow cause liver disease for up to 20% of young people with cystic fibrosis. Ursodeoxycholic acid is a naturally occurring bile acid given to try and prevent liver disease in cystic fibrosis. We searched for trials of th...
Date:   Aug 2010
Title:   Hepatic late adverse effects after antineoplastic treatment for childhood cancer
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Advances in the treatment of childhood cancer over the last decades have greatly improved the survival rates. Unfortunately, the improved prognosis has been accompanied by the occurrence of late, treatment-related complications. One of the adverse effec...
Date:   Dec 2009
Title:   Bariatric surgery for non-alcoholic steatohepatitis in obese patients
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Nonalcoholic fatty liver disease (NAFLD) is the liver manifestation of metabolic syndrome in which obesity and resistance to the insulin action are the hallmark. Fat accumulation in the liver produces inflammation and chronic liver damage, known as non-...
Date:   Jun 2009
Title:   Pharmacological interventions versus no pharmacological intervention for ischaemia reperfusion injury in liver resection surgery performed under vascular control
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Elective liver surgery undertaken for a variety of reasons may require occlusion of the blood supply to the liver in order to reduce bleeding from the cut liver surface. This temporary blood supply interruption can cause liver damage for a variety of re...
Date:   Jan 2009
Title:   Pharmacological interventions for ischaemia reperfusion injury in liver resection surgery performed under vascular control
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Elective liver surgery undertaken for a variety of reasons may require occlusion of the blood supply to the liver in order to reduce bleeding from the cut liver surface. This temporary interruption of blood supply causes liver damage for a variety of re...
Date:   Jan 2009
Title:   Cardiopulmonary interventions to decrease blood loss and blood transfusion requirements for liver resection
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Blood loss during liver resection (partial removal of liver) is one of the important factors affecting the post-operative complications of patients. Allogeneic blood transfusion (using blood donated by a different individual) is associated with increase...
Date:   Nov 2008
Title:   Pharmacological interventions to decrease blood loss and blood transfusion requirements for liver resection
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Blood loss during liver resection (partial removal of liver) is one of the important factors affecting the post-operative complications of patients. Allogeneic blood transfusion (using blood donated by a different individual) is associated with increase...
Date:   Nov 2008
Title:   Ischaemic pre-conditioning for elective liver resections performed under vascular occlusion
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   More than 1000 elective liver resections (planned operation) are performed annually in the United Kingdom alone. When liver resection is performed, the inflow of blood to the liver can be blocked (vascular occlusion), thereby reducing the blood loss. Th...
Date:   Aug 2008
Title:   Systematic Reviews of Treatments for Cirrhosis of the Liver
Publisher:   HealthInsite Topic Page
Description:   Links to systematic reviews of the evidence for the effectiveness of treatments for cirrhosis of the liver.
Date:   Jan 2008
Title:   Methods of vascular occlusion for elective liver resections
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   More than 1000 elective liver resections (planned operation) are performed annually in the United Kingdom alone. When liver resection is performed, the inflow of blood to the liver can be blocked (vascular occlusion), thereby potentially reducing the bl...
Date:   Aug 2007
Title:   Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Probiotics have been proposed as a treatment option for patients with non-alcoholic fatty liver disease and non-alcoholic steatohepatitis because of their balancing role on the flora of the gut that may act as a potential source of hepatotoxic oxidative...
Date:   Nov 2006
Title:   Elective surgery for benign liver tumours
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   The most common benign liver tumours include cavernous haemangioma, focal nodular hyperplasia, and hepatic adenoma. The majority of patients are asymptomatic, and no treatment is indicated. The natural history of haemangioma and focal nodular hyperplasi...
Date:   Nov 2006
Title:   Artificial and bioartificial support systems for liver failure
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Liver failure may develop without pre-existing liver disease (acute liver failure) or with pre-existing liver disease (acute-on-chronic liver failure). Both disorders are serious and may lead to death. Artificial and bioartificial support systems may 'b...
Date:   Nov 2003

Results 1 to 14 displayed.